Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 107

Similar articles for PubMed (Select 24634204)

1.

Updating the OMERACT filter: core areas as a basis for defining core outcome sets.

Kirwan JR, Boers M, Hewlett S, Beaton D, Bingham CO 3rd, Choy E, Conaghan PG, D'Agostino MA, Dougados M, Furst DE, Guillemin F, Gossec L, van der Heijde DM, Kloppenburg M, Kvien TK, Landewé RB, Mackie SL, Matteson EL, Mease PJ, Merkel PA, Ostergaard M, Saketkoo LA, Simon L, Singh JA, Strand V, Tugwell P.

J Rheumatol. 2014 May;41(5):994-9. doi: 10.3899/jrheum.131309. Epub 2014 Mar 15.

2.

How to choose core outcome measurement sets for clinical trials: OMERACT 11 approves filter 2.0.

Boers M, Kirwan JR, Gossec L, Conaghan PG, D'Agostino MA, Bingham CO 3rd, Brooks PM, Landewé R, March L, Simon L, Singh JA, Strand V, Wells GA, Tugwell P.

J Rheumatol. 2014 May;41(5):1025-30. doi: 10.3899/jrheum.131314. Epub 2014 Mar 1.

PMID:
24584913
3.

Updating the OMERACT filter: implications of filter 2.0 to select outcome instruments through assessment of "truth": content, face, and construct validity.

Tugwell P, Boers M, D'Agostino MA, Beaton D, Boonen A, Bingham CO 3rd, Choy E, Conaghan PG, Dougados M, Duarte C, Furst DE, Guillemin F, Gossec L, Heiberg T, van der Heijde DM, Hewlett S, Kirwan JR, Kvien TK, Landewé RB, Mease PJ, Østergaard M, Simon L, Singh JA, Strand V, Wells G.

J Rheumatol. 2014 May;41(5):1000-4. doi: 10.3899/jrheum.131310. Epub 2014 Apr 1.

4.

Updating the OMERACT filter at OMERACT 11.

Kirwan JR, Boers M, Tugwell P.

J Rheumatol. 2014 May;41(5):975-7. doi: 10.3899/jrheum.131306.

PMID:
24788466
5.

Updating the OMERACT filter: implications for imaging and soluble biomarkers.

D'Agostino MA, Boers M, Kirwan J, van der Heijde D, Østergaard M, Schett G, Landewé RB, Maksymowych WP, Naredo E, Dougados M, Iagnocco A, Bingham CO 3rd, Brooks PM, Beaton DE, Gandjbakhch F, Gossec L, Guillemin F, Hewlett SE, Kloppenburg M, March L, Mease PJ, Moller I, Simon LS, Singh JA, Strand V, Wakefield RJ, Wells GA, Tugwell P, Conaghan PG.

J Rheumatol. 2014 May;41(5):1016-24. doi: 10.3899/jrheum.131313. Epub 2014 Mar 1.

6.

Updating the OMERACT filter: implications for patient-reported outcomes.

Kirwan JR, Bartlett SJ, Beaton DE, Boers M, Bosworth A, Brooks PM, Choy E, de Wit M, Guillemin F, Hewlett S, Kvien TK, Landewé RB, Leong AL, Lyddiatt A, March L, May J, Montie PL, Nikaï E, Richards P, Voshaar MM, Smeets W, Strand V, Tugwell P, Gossec L.

J Rheumatol. 2014 May;41(5):1011-5. doi: 10.3899/jrheum.131312. Epub 2014 Mar 1.

PMID:
24584919
7.

Toward a generalized framework of core measurement areas in clinical trials: a position paper for OMERACT 11.

Boers M, Idzerda L, Kirwan JR, Beaton D, Escorpizo R, Boonen A, Magasi S, Sinha I, Stucki G, Tugwell P.

J Rheumatol. 2014 May;41(5):978-85. doi: 10.3899/jrheum.131307. Epub 2014 Mar 1.

PMID:
24584922
8.

Can we decide which outcomes should be measured in every clinical trial? A scoping review of the existing conceptual frameworks and processes to develop core outcome sets.

Idzerda L, Rader T, Tugwell P, Boers M.

J Rheumatol. 2014 May;41(5):986-93. doi: 10.3899/jrheum.131308. Epub 2014 Mar 1. Review.

PMID:
24584917
9.

Developing core outcome measurement sets for clinical trials: OMERACT filter 2.0.

Boers M, Kirwan JR, Wells G, Beaton D, Gossec L, d'Agostino MA, Conaghan PG, Bingham CO 3rd, Brooks P, Landewé R, March L, Simon LS, Singh JA, Strand V, Tugwell P.

J Clin Epidemiol. 2014 Jul;67(7):745-53. doi: 10.1016/j.jclinepi.2013.11.013. Epub 2014 Feb 28.

10.

Updating the OMERACT filter: discrimination and feasibility.

Wells G, Beaton DE, Tugwell P, Boers M, Kirwan JR, Bingham CO 3rd, Boonen A, Brooks P, Conaghan PG, D'Agostino MA, Dougados M, Furst DE, Gossec L, Guillemin F, Helliwell P, Hewlett S, Kvien TK, Landewé RB, March L, Mease PJ, Ostergaard M, Simon L, Singh JA, Strand V, van der Heijde DM.

J Rheumatol. 2014 May;41(5):1005-10. doi: 10.3899/jrheum.131311. Epub 2014 Apr 1.

11.

Domains selection for patient-reported outcomes: current activities and options for future methods.

Tugwell PS, Petersson IF, Boers M, Gossec L, Kirwan JR, Rader T, Sanderson TC, van de Laar MA, Ueffing E, Witter JP.

J Rheumatol. 2011 Aug;38(8):1702-10. doi: 10.3899/jrheum.110389.

PMID:
21807789
12.

OMERACT: an international initiative to improve outcome measurement in rheumatology.

Boers M, Brooks P, Simon LS, Strand V, Tugwell P.

Clin Exp Rheumatol. 2005 Sep-Oct;23(5 Suppl 39):S10-3.

PMID:
16273779
13.

Establishing a core domain set to measure rheumatoid arthritis flares: report of the OMERACT 11 RA flare Workshop.

Bykerk VP, Lie E, Bartlett SJ, Alten R, Boonen A, Christensen R, Furst DE, Hewlett S, Leong AL, Lyddiatt A, March L, May JE, Montie P, Orbai AM, Pohl C, Scholte Voshaar M, Woodworth T, Bingham CO 3rd, Choy EH.

J Rheumatol. 2014 Apr;41(4):799-809. doi: 10.3899/jrheum.131252. Epub 2014 Mar 1. Review.

14.

Outcomes from the Patient Perspective Workshop at OMERACT 6.

Kirwan J, Heiberg T, Hewlett S, Hughes R, Kvien T, Ahlmèn M, Boers M, Minnock P, Saag K, Shea B, Suarez Almazor M, Taal E.

J Rheumatol. 2003 Apr;30(4):868-72. Review.

PMID:
12672218
15.

Development of a Draft Core Set of Domains for Measuring Shared Decision Making in Osteoarthritis: An OMERACT Working Group on Shared Decision Making.

Toupin-April K, Barton J, Fraenkel L, Li L, Grandpierre V, Guillemin F, Rader T, Stacey D, Légaré F, Jull J, Petkovic J, Scholte-Voshaar M, Welch V, Lyddiatt A, Hofstetter C, De Wit M, March L, Meade T, Christensen R, Gaujoux-Viala C, Suarez-Almazor ME, Boonen A, Pohl C, Martin R, Tugwell PS.

J Rheumatol. 2015 Apr 15. pii: jrheum.141205. [Epub ahead of print]

PMID:
25877502
16.

OMERACT endorsement of measures of outcome for studies of acute gout.

Singh JA, Taylor WJ, Dalbeth N, Simon LS, Sundy J, Grainger R, Alten R, March L, Strand V, Wells G, Khanna D, McQueen F, Schlesinger N, Boonen A, Boers M, Saag KG, Schumacher HR, Edwards NL.

J Rheumatol. 2014 Mar;41(3):569-73. doi: 10.3899/jrheum.131246. Epub 2013 Dec 15.

17.

Enhanced Patient Involvement and the Need to Revise the Core Set - Report from the Psoriatic Arthritis Working Group at OMERACT 2014.

Tillett W, Eder L, Goel N, De Wit M, Gladman DD, FitzGerald O, Campbell W, Helliwell PS, Gossec L, Orbai AM, Ogdie A, Strand V, McHugh NJ, Mease PJ.

J Rheumatol. 2015 May 1. pii: jrheum.141156. [Epub ahead of print]

PMID:
25934828
18.

Patient perspective workshop: moving towards OMERACT guidelines for choosing or developing instruments to measure patient-reported outcomes.

Kirwan JR, Fries JF, Hewlett SE, Osborne RH, Newman S, Ciciriello S, van de Laar MA, Dures E, Minnock P, Heiberg T, Sanderson TC, Flurey CA, Leong AL, Montie P, Richards P.

J Rheumatol. 2011 Aug;38(8):1711-5. doi: 10.3899/jrheum.110391.

PMID:
21807790
19.
20.

Progress towards a core set of outcome measures in small-vessel vasculitis. Report from OMERACT 9.

Merkel PA, Herlyn K, Mahr AD, Neogi T, Seo P, Walsh M, Boers M, Luqmani R.

J Rheumatol. 2009 Oct;36(10):2362-8. doi: 10.3899/jrheum.090373.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk